NZ224371A - Method for purifying granulocyte-macrophage colony stimulating factor (gm-csf) - Google Patents

Method for purifying granulocyte-macrophage colony stimulating factor (gm-csf)

Info

Publication number
NZ224371A
NZ224371A NZ224371A NZ22437188A NZ224371A NZ 224371 A NZ224371 A NZ 224371A NZ 224371 A NZ224371 A NZ 224371A NZ 22437188 A NZ22437188 A NZ 22437188A NZ 224371 A NZ224371 A NZ 224371A
Authority
NZ
New Zealand
Prior art keywords
csf
process according
microorganism
glutathione
purifying
Prior art date
Application number
NZ224371A
Other languages
English (en)
Inventor
Thomas C Boone
Original Assignee
Amgen Inc
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Kirin Brewery filed Critical Amgen Inc
Publication of NZ224371A publication Critical patent/NZ224371A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ224371A 1987-04-28 1988-04-26 Method for purifying granulocyte-macrophage colony stimulating factor (gm-csf) NZ224371A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4333187A 1987-04-28 1987-04-28

Publications (1)

Publication Number Publication Date
NZ224371A true NZ224371A (en) 1990-11-27

Family

ID=21926624

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ224371A NZ224371A (en) 1987-04-28 1988-04-26 Method for purifying granulocyte-macrophage colony stimulating factor (gm-csf)

Country Status (15)

Country Link
EP (1) EP0289267B1 (en, 2012)
JP (1) JPH0771506B2 (en, 2012)
KR (1) KR960001740B1 (en, 2012)
AT (1) ATE83780T1 (en, 2012)
AU (1) AU621051B2 (en, 2012)
CA (1) CA1302652C (en, 2012)
DE (1) DE3876843T2 (en, 2012)
ES (1) ES2036680T3 (en, 2012)
FI (1) FI94867C (en, 2012)
GR (1) GR3006984T3 (en, 2012)
IL (1) IL86163A (en, 2012)
NO (1) NO175638C (en, 2012)
NZ (1) NZ224371A (en, 2012)
WO (1) WO1988008428A1 (en, 2012)
ZA (1) ZA882808B (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
EP0719860B1 (en) * 1988-05-13 2009-12-16 Amgen Inc. Process for isolating and purifying G-CSF
JP2517100B2 (ja) * 1989-03-08 1996-07-24 協和醗酵工業株式会社 ヒト顆粒球コロニ―刺激因子活性を有する蛋白質の精製法
GB9107846D0 (en) * 1990-04-30 1991-05-29 Ici Plc Polypeptides
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
US8161889B2 (en) 2006-11-16 2012-04-24 Mitsubishi Heavy Industries, Ltd. Bogie structure for a track vehicle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (en, 2012) * 1982-12-22 1984-10-02 Genentech Inc
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
CN1031465C (zh) * 1984-11-20 1996-04-03 先灵生物技术公司 编码表现有人粒细胞巨口噬细胞和嗜伊红细胞生长因子活性多之肽cDNA克隆
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof

Also Published As

Publication number Publication date
EP0289267B1 (en) 1992-12-23
KR890701616A (ko) 1989-12-21
KR960001740B1 (en) 1996-02-05
NO175638C (no) 1994-11-09
CA1302652C (en) 1992-06-02
EP0289267A2 (en) 1988-11-02
DE3876843T2 (de) 1993-04-29
EP0289267A3 (en) 1989-11-08
ZA882808B (en) 1988-10-20
JPS6427492A (en) 1989-01-30
ATE83780T1 (de) 1993-01-15
IL86163A (en) 1992-11-15
DE3876843D1 (de) 1993-02-04
AU1711588A (en) 1988-12-02
WO1988008428A1 (en) 1988-11-03
NO175638B (en, 2012) 1994-08-01
AU621051B2 (en) 1992-03-05
GR3006984T3 (en, 2012) 1993-06-30
ES2036680T3 (es) 1993-06-01
NO885777D0 (no) 1988-12-27
FI885986L (fi) 1988-12-27
NO885777L (no) 1988-12-27
JPH0771506B2 (ja) 1995-08-02
FI94867C (fi) 1995-11-10
FI94867B (fi) 1995-07-31
IL86163A0 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
EP0077670B1 (en) Human immune interferon
EP0043980B1 (en) Mature human leukocyte interferon a, process for its microbial preparation, intermediates therefor and compositions containing it.
US6482613B1 (en) Microbial production of mature human leukocyte interferons
US5464939A (en) Highly purified protein, production and use thereof
CA1341569C (en) Microbial production of human fibroblast interferon
US5096705A (en) Human immune interferon
US5582824A (en) Recombinant DES-CYS-TYR-CYS human immune interferon
EP1837346A2 (en) Method for purifying granulocyte-colony stimulating factor
EP0165654B1 (en) Purified interleukin 1
EP0818466B1 (en) Purified, biologically active bacterially produced recombinant human CSF-1
HUT56134A (en) Process for producing and purifying recombinant human interleukin-3 and its muteins
AU621051B2 (en) Method for purifying granulocyte-macrophage colony stimulating factor
US5047504A (en) Method for purifying granulocyte-macrophage colony stimulating factor
JPS6363199B2 (en, 2012)
EP0369316A2 (en) Recombinant interleukin-2 hybrid proteins
IL63197A (en) Intraferons for mature human oocytes, their preparation and preparations containing them
PH26492A (en) Recombinant human immune interferon
IE84354B1 (en) Purified, biologically active, bacterially produced recombinant human CSF-1